目的:探讨肾上腺血管内大B 细胞性淋巴瘤的临床病理特征、诊断与鉴别诊断、治疗及预后.方法:回顾性分析肾上腺血管内大B 细胞性淋巴瘤患者的临床资料,并进行组织学观察、免疫组化染色.
患儿,男,7 岁,因"左侧肢体发育迟缓7 年"入院.患儿既往体健,个人史、家族史及过去史无特殊入院查体:神志清楚,言语流利,查体合作.头颅无畸形.嗅觉正常存在;双侧眼球活动自如,双瞳正大等圆,直径2.5mm,直接、间接对光反射均灵敏;左侧肢体较右侧肢体纤细,肌力略差,左侧肢体肌力IV 级,远端III 级,右侧肢体肌力V 级;双侧上、中、下腹壁反射、足底反射等浅反射灵敏、对称;四肢肌腱反射如膝反射、
目的:通过对照分析2014 年度同时实施宫颈液基细胞学筛检和组织学活检的病例,研究液基细胞学检查的敏感性和特异性,分析产生误诊和漏诊的可能原因.材料方法:筛选诊断数据库同时具备液基细胞学检查和组织学活检结果的病例,将其中380例细胞学检查结果为阳性(非典型鳞状细胞ASC、鳞状上皮内病变SIL 以及鳞状细胞癌)纳入研究对象并分析对应活检情况.
Introduction Recent studies suggested that the rearrangement of EML4-ALK in NSCLC cells might be a promising therapeutic target.However,the low ALK positive rate seeks a reliable and cost-effective me
目的:探讨伴有毛细血管扩张型骨肉瘤特征的成骨细胞型骨肉瘤的临床病理特点和生物学行为,提高临床医生及病理医生的认识及诊断水平.方法:应用HE 染色对1例发生于左腓骨伴有毛细血管扩张型骨肉瘤特征的成骨细胞型骨肉瘤进行组织形态学观察,并复习相关文献.
Patients with glioblastomas with a specific mutation in the isocitrate dehydrogenase 1 (IDH1) gene have a better prognosis than those with gliomas with wild-type IDH1.
Objectives Anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) screening is essential to its treatment such as crizotinib.
Background Treatment of metastatic colon carcinoma with the anti-epidermal growth factor receptor antibody cetuximab/panitumumab is reported to be ineffective in KRAS-mutant tumors;therefore,it is nec
Introduction Crizotinib treatment can significantly prolong progression-free survival,increase response rates,and improve the quality of life in patients with advanced and ALK-positive non-small-cell
Background Papillary thyroid carcinoma (PTC) is the most usual histological type among thyroid cancer,accounts for approximately 80 ％,Although PTC is highly curable,some patients still encounter high